Dr. Mecker MöllerFocus: Peritoneal Mesothelioma
University of Miami Sylvester Comprehensive Cancer Center
1475 NW 12th Ave.
Dr. Mecker Möller, a surgical oncologist with the University of Miami, specializes in treating peritoneal mesothelioma with HIPEC. She was the first doctor in South Florida to perform this novel surgery.
About Dr. Mecker G. Möller
Dr. Möller is a surgical oncologist at the University of Miami. She is affiliated with the Sylvester Comprehensive Cancer Center also in Miami, and the Lennar Foundation Medical Center in Coral Gables, FL.
Dr. Mecker Möller is known for treating peritoneal malignancies such as peritoneal mesothelioma. Her treatment plan is recognized for including hyperthermic intraperitoneal chemoperfusion (HIPEC). In fact, Dr. Möller was the first to perform HIPEC on a patient at the University of Miami Hospital.
Medical Degree and Residency
MD National Autonomous University of Nicaragua in Managua, Nicaragua. Dr. Möller completed a residency in General Surgery at Michigan State University in East Lansing, MI.
During her medical career, Dr. Möller has also completed a clinical and research fellowship at the Moffitt Cancer Center in Tampa, FL.
Currently, Dr. Möller is an Associate Professor of Surgery at the University of Miami Miller School of Medicine. She also serves as head of the HIPEC Peritoneal Malignancies Program.
Dr. Möller’s Accomplishments
- Certified by the American Board of Surgery
- Considered the first person in South Florida to perform HIPEC at the Sylvester Comprehensive Cancer Center
- Head of the HIPEC Peritoneal Malignancies Program at the University of Miami Miller School of Medicine
- Speaks English and Spanish
Get Connected to Dr. Mecker Möller
Why Choose Dr. Mecker Möller?
- She is recognized for performing hyperthermic intraperitoneal chemoperfusion.
- She was the first person at the University of Miami to perform HIPEC.
- Many mesothelioma patients under her care have reached a state of remission.
- She has years of experience treating patients with malignancies like peritoneal mesothelioma.
Dr. Mecker Möller: Treating Mesothelioma Patients with HIPEC
At the University of Miami, Dr. Möller is improving the lives of many peritoneal mesothelioma patients by performing HIPEC. Five-year data shows patients undergoing this treatment live longer and have a better quality of life.
The University of Miami Miller School of Medicine was the first in South Florida to provide HIPEC as a form of treatment to patients with peritoneal mesothelioma. A HIPEC procedure typically follows surgery, but some studies suggest that this procedure is even beneficial to mesothelioma patients that aren’t surgical candidates.
HIPEC is typically paired with cytoreductive surgery. Cytoreductive surgery removes a patient’s tumors, and HIPEC helps by extracting any remaining mesothelioma cells.
By pairing cytoreductive surgery with HIPEC many malignant peritoneal mesothelioma patients experience longer survival times – some even reach a state of remission.